Delivery Order SPE2DX15D8003-SPE2DX24F7E2E
Award Date
6/14/24
Potential Completion Date
6/17/24
Potential Value
$8.8K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $5,011.42 firm fixed-price contract has a period of performance through November 8, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which enables...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,272.41 fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of October 19, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,311.87, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract, identified as SPE2DX15D8003|SPE2DX24F7E4R, has a total ceiling value of $2,088.72 and a completion date of July 1, 2024. It is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division. Dakota Drug, Inc. is a key supplier of pharmaceutical and...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2WM8, was made to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to the U.S. Department of Defense's Defense Logistics Agency (DLA). The contract has a firm fixed price and a ceiling value of $5,524.42. It is a delivery order contract with a performance period ending on May 31, 2024. Dakota Drug, Inc. is a key supplier to the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,229.84, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to support medical operations for the U.S. Armed Forces. The contract does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract, which has a firm fixed price of $4,442.65 and an ultimate completion date of January 4, 2024, is part of the DLA Troop Support Medical's ECAT Generation V Program, a large indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug,...
This federal contract award, ID SPE2DB24D8001|SPE2DB25FKZMW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $4,312.20 and a period of performance through April 10, 2025. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,032.16, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,846.07, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on February 26, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...